PCBL Chemical Limited has informed the Exchange about Investor Presentation
PCBL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
PCBL Chemical filed its Q1 FY26 investor update with the exchanges. Consolidated revenue came in at Rs. 2,114 Cr, roughly flat YoY (down 1.5%), while EBITDA fell to Rs. 325 Cr from Rs. 369 Cr, pushing margins down to 15% from 17% a year ago. PAT dropped to Rs. 94 Cr (EPS Rs. 2.5 vs Rs. 3.1). On the operational side, carbon black sales volume grew 2.6% QoQ to 1,54,093 MT and specialty black volumes rose 4.5% QoQ to 16,065 MT. The Aquapharm chemicals arm posted Rs. 382 Cr revenue and Rs. 50 Cr EBITDA, and commissioned an 11,500 MTPA polymer line at Mahad. Management reiterated its FY28 target of 1 million MTPA carbon black capacity, plans to add 30,000 MTPA brownfield capacity soon, and signalled a 20,000 MTPA specialty black line in 3-4 quarters. Subsidiary Nanovace also secured a US patent for next-gen battery nanomaterials.
Flat top line with a clear YoY margin squeeze is a mild negative for near-term sentiment, but the order book growth in specialty blacks, capacity expansion roadmap (FY28: 1 million MTPA target), new Acetylene Black plant and US patent win for battery tech provide a constructive medium-term story. Investors should weigh weaker Q1 profitability against visible capacity-led growth.